Purchase Order 75H71021P00421
- Not listed
- The Indian Health Service awarded a purchase order to Medtox Diagnostics, Inc. on December 30, 2020, for laboratory supplies at the Teec Nos Pos, Arizona facility serving Native American communities. This blanket purchase agreement, with a ceiling value of $8,236.72 and firm fixed-price terms, was completed by December 31, 2021, and has since been closed out with excess funds deobligated. The award was made without set-aside designation, indicating open competitive procurement. Medtox...
- This is a firm fixed-price purchase order awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Medtox Diagnostics, Inc., a subsidiary of Laboratory Corporation of America Holdings (LabCorp). The contract is for urine drug screening and confirmatory testing services to support the IHS's healthcare operations, with a ceiling value of $156,528.79 and a period of performance through September 30, 2025. The contract was competitively...
- This is a firm fixed-price purchase order awarded to Medtox Diagnostics, Inc., a manufacturer of laboratory testing products and services, by the Indian Health Service (IHS), a division of the Department of Health and Human Services. The contract has a ceiling value of $25,000.00 and an ultimate completion date of December 31, 2025. The contract is for the provision of laboratory supplies and testing supplies to support the clinical testing, direct patient care activities, and drug screening...
- Medtox Diagnostics, Inc. was awarded a $19,894.20 firm fixed price purchase order by the Department of Health and Human Services Indian Health Service to provide laboratory testing products for the Lawton, Oklahoma IHS facility. As a prime contractor and manufacturer, Medtox will deliver urine drug screening tests and other miscellaneous laboratory supplies to support routine clinical testing services. No set-aside designation was used for this award, which is to be completed by March 29,...
- The Department of Health and Human Services Indian Health Service awarded a $20,078.10 firm fixed price delivery order contract to Medtox Laboratories, Inc. for drug test profiles and supplies. Medtox Laboratories, Inc. will deliver the requested products and services under the Multiple Award Schedule contract vehicle. Performance will take place in Burlington, North Carolina through October 31, 2021. Medtox Laboratories is a division of Laboratory Corporation of America Holdings. This...
- This federal contract award, valued at $23,853.17, was issued by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services, to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The contract is for the provision of laboratory testing supplies for the IHS laboratory department. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Medtox Laboratories Inc. holds a...
- Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings, has received a $46,457.76 delivery order from the Department of Health and Human Services Indian Health Service (IHS) for laboratory equipment and supplies. The firm fixed price order was issued against Medtox's Law Enforcement & Security Services (FSS-84) Multiple Award Schedule contract with the General Services Administration, with no set-aside designation. The products will be delivered to the IHS...
- The Department of Health and Human Services Indian Health Service awarded a $19,881.34 firm fixed price delivery order contract to Medtox Laboratories, Inc. for lab supplies. The contract was awarded on April 17, 2023 under the Multiple Award Schedule contracting vehicle and has a period of performance through December 31, 2023. Place of performance will be in Lawton, Oklahoma. No set-aside designation was used for this award. Medtox Laboratories, Inc. is a division of Laboratory Corporation...
- The Department of Health and Human Services Indian Health Service awarded a $10,182.21 delivery order contract to Medtox Laboratories, Inc. for drug profile and supplies. Medtox Laboratories, Inc. will deliver the requested products and services under the Multiple Award Schedule contract vehicle. The contract has no set-aside designation and requires completion by December 5, 2022. Performance will take place in Burlington, North Carolina. Medtox Laboratories, Inc. is a division of Laboratory...
- The Department of Health and Human Services Indian Health Service awarded a $28,475 firm fixed price delivery order against the Multiple Award Schedule contract vehicle to Medtox Laboratories, Inc. for drug screen services. Medtox Laboratories, Inc. is a division of Laboratory Corporation of America Holdings and will perform the drug screens in Lawton, Oklahoma by the October 31, 2020 completion date. No set-aside designation was used for this contract. The Indian Health Service supports...
The Indian Health Service awarded a $26,344.36 firm fixed-price purchase order to Medtox Diagnostics, Inc. for drugs of abuse testing supplies on December 28, 2020, with an ultimate completion date of September 16, 2024. The contract, which has been closed out, was performed in Crownpoint, New Mexico and was awarded without a set-aside designation. Medtox Diagnostics, a subsidiary of Laboratory Corporation of America Holdings (LabCorp), is a manufacturer of laboratory testing products and diagnostic solutions headquartered in Burlington, North Carolina. This purchase order supports IHS's clinical laboratory operations serving Native American communities, continuing a pattern of competitive awards to Medtox Diagnostics for drug screening tests and laboratory supplies across multiple IHS facilities. As a child entity of LabCorp, Medtox Diagnostics leverages its parent company's extensive capabilities in diagnostic testing and reference laboratory services, which have earned LabCorp numerous federal contracts across the Department of Defense, Department of Veterans Affairs, Centers for Disease Control and Prevention, and other agencies. The contract award demonstrates the vendor's established ability to compete successfully in open market procurements for specialized medical laboratory supplies that support direct patient care activities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Close Out | ($1k) | 12/7/25 | |
| P00002 | Supplemental Agreement for work within scope | $1.0k | 8/15/24 | |
| P00001 | Funding Only Action | $11.0k | 9/17/21 | |
| Not listed | Not listed | $15.5k | 12/30/20 |